ATE107856T1 - Lokal anzuwendende, pyridinolcarbamat enthaltende arzneizubereitungen. - Google Patents

Lokal anzuwendende, pyridinolcarbamat enthaltende arzneizubereitungen.

Info

Publication number
ATE107856T1
ATE107856T1 AT90120881T AT90120881T ATE107856T1 AT E107856 T1 ATE107856 T1 AT E107856T1 AT 90120881 T AT90120881 T AT 90120881T AT 90120881 T AT90120881 T AT 90120881T AT E107856 T1 ATE107856 T1 AT E107856T1
Authority
AT
Austria
Prior art keywords
pyridinol carbamate
topical medications
medications containing
containing pyridinol
carbamate
Prior art date
Application number
AT90120881T
Other languages
English (en)
Inventor
Ruggero Angeletti
Original Assignee
Ruggero Angeletti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ruggero Angeletti filed Critical Ruggero Angeletti
Application granted granted Critical
Publication of ATE107856T1 publication Critical patent/ATE107856T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT90120881T 1989-11-07 1990-10-31 Lokal anzuwendende, pyridinolcarbamat enthaltende arzneizubereitungen. ATE107856T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22279A IT1239475B (it) 1989-11-07 1989-11-07 Formulazioni farmaceutiche per uso topico a base di piridinolcarbammato e suoi polimeri instabili

Publications (1)

Publication Number Publication Date
ATE107856T1 true ATE107856T1 (de) 1994-07-15

Family

ID=11194093

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90120881T ATE107856T1 (de) 1989-11-07 1990-10-31 Lokal anzuwendende, pyridinolcarbamat enthaltende arzneizubereitungen.

Country Status (4)

Country Link
EP (1) EP0433624B1 (de)
AT (1) ATE107856T1 (de)
DE (1) DE69010316T2 (de)
IT (1) IT1239475B (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL126013C (de) * 1963-04-13 1900-01-01

Also Published As

Publication number Publication date
IT1239475B (it) 1993-11-02
IT8922279A0 (it) 1989-11-07
EP0433624A1 (de) 1991-06-26
DE69010316T2 (de) 1994-12-01
EP0433624B1 (de) 1994-06-29
IT8922279A1 (it) 1991-05-07
DE69010316D1 (de) 1994-08-04

Similar Documents

Publication Publication Date Title
FI955091L (fi) Parannetut farmaseuttisesti hyväksyttävät seokset, jotka sisältävät alkoholia ja hydrofobista lääkettä
CA2029524A1 (en) Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
NO982580L (no) Nye taxoider, deres fremstilling samt farmas°ystiske preparater inneholdende taxoidene
FI953533L (fi) Transdermaalinen terapeuttinen järjestelmä, jossa on galantamiinia vaikuttavana aineena
ATA244992A (de) Stabilisiertes pharmazeutisches mittel, enthaltend einen hmg-coa-reduktase-inhibitor wirkstoff
FI952825L (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
ATE121295T1 (de) Augentropfenarzneimittel.
PT1040830E (pt) Medicamento para doencas neurodegenerativas
EP0382066A3 (de) Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
CA2136331A1 (en) New pharmaceutical uses of krill enzymes
FI954111A7 (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset v almisteet
IT1275816B1 (it) Composizioni farmaceutiche solide per uso vaginale
DK0665741T3 (da) Topiske, oftalmiske, farmaceutiske bærere
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
PT91772A (pt) Processo para a preparacao de composicoes estabilizantes para polimeros halogenados a base de beta-dicetona, hidrotalcite e dihidropiridina e dos respectivos polimeros assim estabilizados
WO1994027584A3 (en) Arylating medicaments
DE69010316D1 (de) Lokal anzuwendende, Pyridinolcarbamat enthaltende Arzneizubereitungen.
DE69024060D1 (de) Osteogenesis-stimulierende mittel.
AU644621B2 (en) Pharmaceutical composition for treating or preventing retroviral infections
DE69018914D1 (de) Pharmakologisch aktive Präparate und sie enthaltende Arzneimittel.
CA2113080A1 (en) Topical composition containing penciclovir
DE3869156D1 (de) Fungizide 2-anilinthiazoline.
FI931159A7 (fi) Dosaerosoler, som innehåller som aktivt ämne flezelastin och med detta relaterade strukturer
ITTO930179A1 (it) Farmaci attivi contro l'agente eziologico della sindrome da astenia cronica
IT1237084B (it) Sensibilizzazione di composti metallorganici per la polimerizzazione radicalica fotocatalizzata e stabilizzazione dei preparati.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties